| Primary |
| Depression |
41.5% |
| Sleep Disorder |
19.5% |
| Anxiety Disorder |
9.8% |
| Insomnia |
4.9% |
| Anxiety |
2.4% |
| Essential Hypertension |
2.4% |
| Gallbladder Cholesterolosis |
2.4% |
| Hypertension |
2.4% |
| Major Depression |
2.4% |
| Obstetrical Pulmonary Embolism |
2.4% |
| Osteoporosis |
2.4% |
| Rheumatoid Arthritis |
2.4% |
| Schizophrenia |
2.4% |
| Vena Cava Filter Insertion |
2.4% |
|
| Suicide Attempt |
13.0% |
| Tremor |
8.7% |
| Urinary Retention |
8.7% |
| Angioedema |
4.3% |
| Delirium |
4.3% |
| Hyperhidrosis |
4.3% |
| Hyponatraemia |
4.3% |
| International Normalised Ratio Decreased |
4.3% |
| Monoplegia |
4.3% |
| Nausea |
4.3% |
| Pancreatic Enzymes Increased |
4.3% |
| Pancreatitis |
4.3% |
| Periodontal Disease |
4.3% |
| Pregnancy |
4.3% |
| Somnolence |
4.3% |
| Systemic Inflammatory Response Syndrome |
4.3% |
| Thirst |
4.3% |
| Urticaria |
4.3% |
| Ventricular Hypokinesia |
4.3% |
|
| Secondary |
| Product Used For Unknown Indication |
61.3% |
| Depression |
11.2% |
| Drug Abuse |
4.9% |
| Anger |
3.7% |
| Personality Disorder |
3.4% |
| Rabies |
2.8% |
| Anxiety |
2.1% |
| Hypertension |
2.0% |
| Drug Exposure In Utero |
1.1% |
| Self Injurious Behaviour |
0.9% |
| Ill-defined Disorder |
0.8% |
| Sleep Disorder |
0.8% |
| Type 2 Diabetes Mellitus |
0.8% |
| Agitation |
0.6% |
| Bipolar Disorder |
0.6% |
| Bipolar I Disorder |
0.6% |
| Drug Use For Unknown Indication |
0.6% |
| Insomnia |
0.6% |
| Myocardial Ischaemia |
0.6% |
| Schizophrenia, Paranoid Type |
0.6% |
|
| Sopor |
17.0% |
| Urinary Retention |
12.8% |
| Tachycardia |
6.4% |
| Micturition Disorder |
5.3% |
| Overdose |
5.3% |
| Psychomotor Hyperactivity |
5.3% |
| Self Injurious Behaviour |
5.3% |
| Toxicity To Various Agents |
5.3% |
| Abortion Missed |
4.3% |
| Liver Injury |
4.3% |
| Thrombosis |
4.3% |
| Completed Suicide |
3.2% |
| Drug Exposure During Pregnancy |
3.2% |
| Sluggishness |
3.2% |
| Syncope |
3.2% |
| Vertigo |
3.2% |
| Abnormal Behaviour |
2.1% |
| Cardiac Arrest |
2.1% |
| Extrapyramidal Disorder |
2.1% |
| Hypoglycaemia Neonatal |
2.1% |
|
| Concomitant |
| Depression |
23.3% |
| Product Used For Unknown Indication |
21.9% |
| Drug Use For Unknown Indication |
12.4% |
| Hyperlipidaemia |
4.6% |
| Anxiety |
3.9% |
| Bipolar Disorder |
3.4% |
| Type 2 Diabetes Mellitus |
3.4% |
| Hypertension |
3.3% |
| Sleep Disorder |
3.3% |
| Personality Disorder |
2.9% |
| Crohn's Disease |
2.4% |
| Suspiciousness |
2.4% |
| Insomnia |
2.3% |
| Breast Cancer |
2.0% |
| Generalised Anxiety Disorder |
1.5% |
| Intentional Self-injury |
1.5% |
| Pain |
1.5% |
| Prophylaxis |
1.5% |
| Essential Hypertension |
1.3% |
| Hypothyroidism |
1.3% |
|
| Tachycardia |
23.5% |
| Sopor |
17.4% |
| Tremor |
7.0% |
| Vertigo |
5.2% |
| Anaemia |
3.5% |
| Presyncope |
3.5% |
| Sexual Abuse |
3.5% |
| Somnolence |
3.5% |
| Thrombocytopenia |
3.5% |
| Vomiting |
3.5% |
| Death |
2.6% |
| Dysgeusia |
2.6% |
| Intentional Self-injury |
2.6% |
| International Normalised Ratio Increased |
2.6% |
| Liver Disorder |
2.6% |
| Liver Injury |
2.6% |
| Renal Failure Acute |
2.6% |
| Speech Disorder |
2.6% |
| Syncope |
2.6% |
| Thrombosis |
2.6% |
|
| Interacting |
| Depression |
18.2% |
| Anger |
10.9% |
| Bipolar I Disorder |
9.1% |
| Drug Use For Unknown Indication |
7.3% |
| Obsessive-compulsive Disorder |
7.3% |
| Premedication |
7.3% |
| Sleep Disorder |
7.3% |
| Abdominal Pain |
5.5% |
| Anxiety |
5.5% |
| Dementia Of The Alzheimer's Type, With Depressed Mood |
5.5% |
| Nausea |
5.5% |
| Paranoia |
5.5% |
| Meningitis |
1.8% |
| Meningitis Enterococcal |
1.8% |
| Sedation |
1.8% |
|
| Tongue Spasm |
28.6% |
| Drug Interaction |
14.3% |
| Serotonin Syndrome |
14.3% |
| Off Label Use |
7.1% |
| Oxygen Saturation Decreased |
7.1% |
| Psychomotor Skills Impaired |
7.1% |
| Regurgitation |
7.1% |
| Sopor |
7.1% |
| Toxicity To Various Agents |
7.1% |
|
